Rating History for Regeneron Pharma (regn) by Chardan Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/12/2016 | N/A | Upgrade | Neutral (Sell) |
350.00 (N/A) |
372.83 (906.54) |
143.15% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/12/2016 | N/A | Upgrade | Neutral (Sell) |
350.00 (N/A) |
372.83 (906.54) |
143.15% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
